Torsdag 26 December | 23:14:39 Europe / Stockholm

Kalender

Tid*
2025-03-06 N/A Kvartalsrapport 2025-Q2
2024-11-11 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2024-11-08 - Årsstämma
2024-09-20 - Bokslutskommuniké 2024
2024-03-07 - Kvartalsrapport 2024-Q2
2023-11-17 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 - Årsstämma
2023-09-28 - Bokslutskommuniké 2023
2023-04-24 - Extra Bolagsstämma 2023
2023-03-23 - Kvartalsrapport 2023-Q2
2022-11-17 - Årsstämma
2022-10-25 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 - Bokslutskommuniké 2022
2022-06-29 - Extra Bolagsstämma 2022
2022-02-24 - Kvartalsrapport 2022-Q2
2021-10-29 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 - Årsstämma
2021-09-15 - Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2022-06-10 07:50:00

Managers' transactions, 10 June 2022 at 08:50 (EEST)

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 16035/6/4

____________________________________________

Transaction date: 2022-06-08

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 33 Unit price: 1.9900 EUR

(2): Volume: 1,952 Unit price: 1.9900 EUR

(3): Volume: 144 Unit price: 2.0000 EUR

(4): Volume: 2,000 Unit price: 1.9780 EUR

(5): Volume: 628 Unit price: 1.9700 EUR

(6): Volume: 3.000 Unit price:  1.9780 EUR

(7): Volume: 1,365 Unit price: 1.9760 EUR

(8): Volume: 2,611 Unit price: 1.9780 EUR

(9): Volume: 1,000 Unit price: 1.9780 EUR

(10): Volume: 368 Unit price: 1.9620 EUR

(11): Volume: 568 Unit price: 1.9780 EUR

(12): Volume: 552 Unit price: 1.9780 EUR

(13): Volume: 74 Unit price: 1.9500 EUR

(14): Volume: 45 Unit price: 1.9500 EUR

(15): Volume: 99 Unit price: 1.9500 EUR

(16): Volume: 13 Unit price: 1.9920 EUR

(17): Volume: 1,392 Unit price: 1.9920 EUR

(18): Volume: 198 Unit price: 1.9920 EUR

(19): Volume: 448 Unit price: 1.9650 EUR

(20): Volume: 421 Unit price: 2.000 EUR

(21): Volume: 322 Unit price: 1.9970 EUR

(22): Volume: 901 Unit price: 2.000 EUR

(23): Volume: 3,178 Unit price: 2.0300 EUR

(24): Volume: 564 Unit price: 2.0300 EUR

(25): Volume: 94 Unit price: 2.0300 EUR

(26): Volume: 438 Unit price: 2.0225 EUR

(27): Volume: 232 Unit price: 2.0350 EUR

(28): Volume: 541 Unit price: 2.0350 EUR

(29): Volume: 500 Unit price: 2.0350 EUR

(30): Volume: 739 Unit price: 2.0350 EUR

(31): Volume: 580 Unit price: 2.0350 EUR

Aggregated transactions

(31): Volume: 25,000 Volume weighted average price: 1.99503 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com

Certified Adviser:
Oaklins Merasco Ltd. tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it's also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.